Naglaa Zayed

868 total citations
63 papers, 665 citations indexed

About

Naglaa Zayed is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Naglaa Zayed has authored 63 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Epidemiology, 45 papers in Hepatology and 9 papers in Molecular Biology. Recurrent topics in Naglaa Zayed's work include Liver Disease Diagnosis and Treatment (44 papers), Hepatitis C virus research (35 papers) and Hepatitis B Virus Studies (18 papers). Naglaa Zayed is often cited by papers focused on Liver Disease Diagnosis and Treatment (44 papers), Hepatitis C virus research (35 papers) and Hepatitis B Virus Studies (18 papers). Naglaa Zayed collaborates with scholars based in Egypt, United Kingdom and Denmark. Naglaa Zayed's co-authors include Gamal Esmat, Ayman Yosry, Noha G. Bader El Din, Mostafa K. El Awady, Ashraf A. Tabll, Abdel‐Rahman N. Zekri, Wafaa Elakel, Reem El‐Shenawy, Abeer A. Bahnassy and Maissa El Raziky and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gut and Journal of Hepatology.

In The Last Decade

Naglaa Zayed

59 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naglaa Zayed Egypt 15 444 428 140 101 45 63 665
Hsing‐Tao Kuo Taiwan 13 446 1.0× 482 1.1× 61 0.4× 33 0.3× 25 0.6× 52 643
Jen‐Eing Jeng Taiwan 17 391 0.9× 381 0.9× 107 0.8× 47 0.5× 81 1.8× 26 643
Xiaoguang Dou China 16 388 0.9× 377 0.9× 112 0.8× 35 0.3× 46 1.0× 72 638
María Trapero-Marugán Spain 14 236 0.5× 250 0.6× 74 0.5× 34 0.3× 58 1.3× 28 441
Mohamed Shaker Egypt 12 347 0.8× 493 1.2× 64 0.5× 58 0.6× 44 1.0× 46 704
Martin‐Walter Welker Germany 13 412 0.9× 507 1.2× 262 1.9× 207 2.0× 49 1.1× 39 867
Martine Lapalus France 14 679 1.5× 704 1.6× 79 0.6× 58 0.6× 85 1.9× 31 869
Maria Stella De Mitri Italy 11 497 1.1× 506 1.2× 93 0.7× 28 0.3× 69 1.5× 23 642
Mitsuaki Sato Japan 10 436 1.0× 463 1.1× 42 0.3× 25 0.2× 51 1.1× 35 581
Elisabetta Degasperi Italy 19 918 2.1× 887 2.1× 102 0.7× 55 0.5× 32 0.7× 82 1.2k

Countries citing papers authored by Naglaa Zayed

Since Specialization
Citations

This map shows the geographic impact of Naglaa Zayed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naglaa Zayed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naglaa Zayed more than expected).

Fields of papers citing papers by Naglaa Zayed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naglaa Zayed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naglaa Zayed. The network helps show where Naglaa Zayed may publish in the future.

Co-authorship network of co-authors of Naglaa Zayed

This figure shows the co-authorship network connecting the top 25 collaborators of Naglaa Zayed. A scholar is included among the top collaborators of Naglaa Zayed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naglaa Zayed. Naglaa Zayed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Elrahman, Mohamed Abd, Ahmed Khairy, Ayman Yosry, et al.. (2023). The Impact of interferon lambda 3 Polymorphism on Hepato-Cellular Carcinoma Progression in Hepatitis C Virus Patients: Treatment-Naïve and Experienced. Asian Pacific Journal of Cancer Prevention. 24(1). 215–221. 2 indexed citations
3.
Adel, Heba, et al.. (2023). Clinical Significance of Evaluation of Monocytic Receptors in Patients with Hepatitis C Virus Infection. Viral Immunology. 36(7). 475–483. 1 indexed citations
4.
Shousha, Hend Ibrahim, et al.. (2023). Screening for maternal cytomegalovirus infection during pregnancy and pregnancy outcome in patients with liver disease: an observational study. BMC Infectious Diseases. 23(1). 210–210. 2 indexed citations
5.
Yosry, Ayman, Naglaa Zayed, Reham M. Dawood, et al.. (2022). Highly Sensitive Serum miRNA Panel for the Diagnosis of Hepatocellular Carcinoma in Egyptian Patients with HCV-Related HCC. Laboratory Medicine. 53(5). 523–529. 6 indexed citations
6.
Elshaarawy, Omar, et al.. (2022). Acoustic radiation force impulse to measure liver stiffness and predict hepatic decompensation in pregnancy with cirrhosis: A cohort study. Arab Journal of Gastroenterology. 23(2). 89–94. 1 indexed citations
8.
Zayed, Naglaa, et al.. (2021). Inter-method variability of hepatitis B surface antigen quantification in a cohort of Egyptian patients with chronic hepatitis B virus. Arab Journal of Gastroenterology. 22(2). 151–157. 2 indexed citations
9.
Zayed, Naglaa, et al.. (2019). Liver stiffness measurement by acoustic radiation forced impulse and transient elastography in patients with intrahepatic cholestasis. European Journal of Gastroenterology & Hepatology. 31(4). 520–527. 6 indexed citations
10.
Yosry, Ayman, Eman Medhat, Naglaa Zayed, et al.. (2018). Efficacy and safety of sofosbuvir‐based therapy in hepatitis C virus recurrence post living donor liver transplant: A real life egyptian experience. Journal of Medical Virology. 91(4). 668–676. 2 indexed citations
12.
Din, Noha G. Bader El, Ghada M. Salum, Marwa K. Ibrahim, et al.. (2015). Association of Myxovirus Resistance Gene Promoter Polymorphism with Response to Combined Interferon Treatment and Progression of Liver Disease in Chronic HCV Egyptian Patients. Journal of Interferon & Cytokine Research. 35(8). 641–648. 10 indexed citations
13.
Fouad, Rabab, et al.. (2015). Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D. Journal of Medical Virology. 88(5). 837–842. 22 indexed citations
14.
Meshaal, Safa, et al.. (2014). Increased DNA Damage in Hepatitis C Virus-Related Hepatocellular Carcinoma. DNA and Cell Biology. 33(12). 884–890. 12 indexed citations
15.
Saad, Yasmin, Maissa El Raziky, Naglaa Zayed, et al.. (2013). Hepatitis C genotype 4 with normal transaminases: Correlation with fibrosis and response to treatment, a cohort Egyptian study of 4277 patients. Clinics and Research in Hepatology and Gastroenterology. 37(5). 479–484. 7 indexed citations
16.
Mabrouk, Mahasen, Wahid Doss, Naglaa Zayed, Shimaa Afify, & Gamal Esmat. (2013). Impact of Serum Alpha-fetoprotein Levels on the Response to Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C. Journal of Gastroenterology and Hepatology Research. 2(5). 597–601. 3 indexed citations
17.
Zayed, Naglaa, et al.. (2013). Evaluation of the diagnostic value of serum and tissue apoptotic cytokeratin-18 in patients with chronic hepatitis C. Arab Journal of Gastroenterology. 14(2). 68–72. 10 indexed citations
18.
Zekri, Abdel‐Rahman N., Abeer A. Bahnassy, Waleed Mohamed, et al.. (2013). Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon. Virology Journal. 10(1). 218–218. 9 indexed citations
19.
Zekri, Abdel‐Rahman N., Hend Ibrahim Shousha, Eman D. El Desouky, et al.. (2013). Disease Progression from Chronic Hepatitis C to Cirrhosis and Hepatocellular Carcinoma is Associated with Increasing DNA Promoter Methylation. Asian Pacific Journal of Cancer Prevention. 14(11). 6721–6726. 33 indexed citations
20.
Zayed, Naglaa, Wafaa Elakel, Wahid Doss, et al.. (2012). The assessment of data mining for the prediction of therapeutic outcome in 3719 Egyptian patients with chronic hepatitis C. Clinics and Research in Hepatology and Gastroenterology. 37(3). 254–261. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026